Is Wesfarmers stock a buy right now?
Wesfarmers Limited (ASX: WES) stands out as a cornerstone of Australia’s retail and industrial landscape, attracting a broad base of both institutional and retail investors. As of early May 2025, the stock trades at around AUD $79.56, with an average daily volume of approximately 1.1 million shares—demonstrating high liquidity and staying power on the Australian Securities Exchange. Recent months have seen Wesfarmers advance its integration of the Kmart and Target brands, invest in digital capabilities, and expand into health with Priceline Pharmacy, providing new levers for future growth. Analysts interpret the continuing uptrend—reflected by the share price sitting above all major moving averages—as a sign of robust underlying confidence, even as short-term technical signals suggest a pause may occur. In the broader context, Wesfarmers’ diversification acts as a buffer against retail sector volatility and economic cycles, positioning the company well within Australia’s economic framework. Based on the consensus from over 35 national and international banks, the stock’s target price has been set at AUD $103.43, pointing towards broad expert confidence in Wesfarmers' ongoing strategy and stable financial footing. For investors seeking exposure to a well-managed, resilient, and diversified Australian leader, Wesfarmers warrants close consideration.
- Consistent revenue and profit growth across diverse business divisions.
- Industry leadership with dominant brands like Bunnings and Kmart.
- Ongoing digital transformation driving efficiency and new opportunities.
- Strong dividend yield supported by solid cash flows.
- Lower than market average volatility (beta of 0.79) enhances portfolio stability.
- Short-term overbought technicals may lead to brief price consolidation.
- Retail segment faces intensifying competition from online market entrants.
- What is Wesfarmers?
- How much is Wesfarmers stock?
- Our full analysis on Wesfarmers </b>stock
- How to buy Wesfarmers stock in Australia?
- Our 7 tips for buying Wesfarmers stock
- The latest news about Wesfarmers
- FAQ
Why trust HelloSafe?
At HelloSafe, our expert has been monitoring Wesfarmers' performance for more than three years. Each month, hundreds of thousands of Australians rely on us to break down market trends and pinpoint the most promising investment opportunities. Our analyses are provided purely for informational purposes and do not represent investment advice. In line with our ethical guidelines, we have never received, and will never accept, any compensation from Wesfarmers.
What is Wesfarmers?
| Indicator | Value | Analysis |
|---|---|---|
| 🏳️ Nationality | Australian | Headquartered in Perth, Wesfarmers is one of Australia's largest and most diversified firms. |
| 💼 Market | Australian Securities Exchange (ASX) | Listed on the ASX, making it accessible to local investors and widely included in local indices. |
| 🏛️ ISIN code | AU000000WES1 | Unique identifier for the stock, used in all global trading and settlement systems. |
| 👤 CEO | Rob Scott | CEO since 2017, Scott leads ongoing digital and health diversification initiatives. |
| 🏢 Market cap | AUD 90.30 billion | Large-cap status provides stability, liquidity, and visibility among Australian blue chips. |
| 📈 Revenue | AUD 23.49 billion (H1 FY2025) | Modest year-on-year growth reflects strength across Wesfarmers' core businesses. |
| 💹 EBITDA | Not publicly specified, but typically ~10–12% margin | Indicates robust operating cash flow; precise figure not reported for the half-year. |
| 📊 P/E Ratio (Price/Earnings) | 33.06 | P/E above sector average; signals growth expectations but also potentially rich valuation. |
How much is Wesfarmers stock?
The price of Wesfarmers stock is rising this week. As of now, shares are trading at AUD $79.56, reflecting a 0.12% gain over the last 24 hours and a robust 5.04% increase compared to last week. Wesfarmers commands a market capitalisation of AUD 90.30 billion, with an average volume of approximately 1.1 million shares traded daily over the past three months. The company is valued at a P/E ratio of 33.06, offers a dividend yield of 2.54%, and has a stock beta of 0.79, signalling lower volatility than the broader market. This recent momentum positions Wesfarmers as a stable option for investors seeking long-term value with moderate price fluctuations.
Check out the best brokers in Australia!Compare brokersOur full analysis on Wesfarmers stock
Having reviewed Wesfarmers Limited’s most recent half-year financials and its robust share price trajectory over the last three years, we have applied our proprietary analytical algorithms—synthesizing signals from key financial metrics, technical indicators, market trends, and peer benchmarking. The results spotlight a conglomerate demonstrating not only financial resilience but also dynamic strategic execution. So, why might Wesfarmers stock once again become a strategic entry point into Australia’s diversified consumer and industrial sector in 2025?
Recent Performance and Market Context
Wesfarmers’ performance throughout 2024 and into early 2025 has underscored its stature as a cornerstone of the ASX. The share price has advanced decisively, reaching a new 52-week high at AUD $79.56, with a compelling 13.37% gain over the previous six months and a five percent surge just this past week. This appreciation is underpinned by a market capitalization standing at AUD 90.3 billion and a modest intraday uptick (+0.12%), indicating ongoing investor confidence and positive market engagement.
Recent positive developments include the seamless integration of Kmart and Target operations, driving operational synergies and brand strength, and a continued commitment to scale digital capabilities through Wesfarmers OneDigital—a key initiative as the retail sector undergoes structural digital transformation. Coupled with strategic health sector expansion, particularly the acquisition and growth of the Priceline Pharmacy and Clear Skincare brands, Wesfarmers has effectively diversified its earnings base.
Macroeconomically, Australia’s stable consumer demand profile, tailwinds in the home improvement segment, and supportive fiscal policy for innovation and clean energy provide an auspicious backdrop—positioning Wesfarmers to capture cyclical upside in the retail, industrial, and digital segments.
Technical Analysis
From a technical vantage, Wesfarmers continues to display formidable bullish momentum. The share price, at AUD $79.56, sits above all key moving averages—20-day EMA (75.29), 50-day EMA (73.88), 100-day EMA (72.89), and 200-day SMA (71.44)—affirming the presence of a persistent and mature uptrend. Technical signals such as a positive MACD (+1.63) reinforce this constructive outlook.
While the daily RSI of 74.06 ordinarily gestures towards overbought conditions—potentially foreshadowing a short-term consolidation—it is also characteristic of the early stages of a sustained bullish phase among leading blue-chips during strong sector rotations. Notably, the key support levels at AUD 78.03, 77.47, and 77.10 provide robust technical floors, suggesting that any pullbacks could be contained within a bullish structure, with buyers likely to re-emerge at these junctures.
Momentum is further supported by an analyst technical consensus registering as a “Strong Buy”, with target prices clustered around a 30% premium to current levels, highlighting both institutional optimism and substantial headroom for appreciation.
Fundamental Analysis
Wesfarmers' fundamental credentials remain unimpeachable. For the half-year ended December 2024, the company reported revenue of AUD 23.49 billion—a 3.6% year-on-year expansion—supported by net profit after tax of AUD 1.47 billion and EPS of AUD 2.29. This recurring growth, set against the modest volatility of its beta (0.79), underscores a defensive quality rarely found among conglomerates of this scale.
| Metric | Value |
|---|---|
| Revenue (HY Dec 2024) | AUD 23.49 billion |
| Net Profit After Tax | AUD 1.47 billion |
| EPS | AUD 2.29 |
| Year-On-Year Revenue Growth | 3.6% |
| Beta | 0.79 |
| P/E | 33.06 |
| Forward P/E | 31.35 |
| Price-to-Sales | 2.01 |
| Dividend Yield | 2.54% |
Valuation metrics are equally instructive. With a P/E of 33.06 and forward P/E of 31.35, Wesfarmers trades at a fair premium to the broader market, reflecting both the resilience of its earnings and the optionality embedded in new growth initiatives. The price-to-sales ratio of 2.01 is attractive given the industry’s persistent re-rating and high cash flow generativity. Dividend yield, at 2.54%, further sweetens the long-term investor proposition—especially in the context of Australia’s franking credit regime, which materially enhances after-tax returns.
Crucially, Wesfarmers' enduring strengths—in brand dominance (Bunnings, Kmart, Officeworks), broad sectoral exposure, digital innovation, and robust market share—position it at the nexus of both defensive stability and strategic growth potential. The company’s diversified revenue base, strong governance under CEO Rob Scott, and sustained reinvestment into growth vectors reinforce its credentials as a blue-chip anchor in any portfolio.
Volume and Liquidity
Analyzing liquidity, Wesfarmers averages approximately 1.1 million shares traded daily over the past three months—testament to sustained investor participation and depth of market. This high and reliable liquidity is instrumental in facilitating dynamic valuation adjustments and helps insulate the stock from episodic market inefficiency.
Furthermore, its widely held shareholder base (more than 495,000 investors) serves to dampen volatility while providing a deep reservoir of capital ready to participate in future capital management or growth initiatives. This liquidity profile acts as both a buffer and a catalyst during periods of sector reweighting or macro-driven rotations.
Catalysts and Positive Outlook
Wesfarmers is uniquely positioned to leverage a suite of potent growth catalysts:
- Digital Transformation: Continued acceleration of its OneDigital platform, unifying e-commerce and data-driven innovation, stands to unlock cross-divisional efficiency and capture incremental share from pure-play online competitors.
- Health Sector Expansion: Growth across health and wellness, particularly through Priceline Pharmacy and Clear Skincare, unlocks exposure to secular themes—ageing demographics and increased health expenditure—distinctly resilient to economic cycles.
- Lithium Joint Venture: Investment in a vertically integrated lithium operation reflects foresight into the energy transition narrative, with potential for outsized returns as demand for battery-grade materials escalates globally.
- Retail Network Optimisation: Streamlining the national Kmart and Target footprint supports margin expansion and aligns fixed costs with changing consumer preferences, enhancing operational leverage.
- ESG and Sustainability Initiatives: Commitment to environmental, social, and governance best practice not only reduces risk but also broadens the investor base to global institutions with sustainability mandates.
These catalysts, set against a supportive regulatory environment and robust Australian consumption trends, cultivate an environment ripe for continued value creation.
Investment Strategies
For varying investment horizons, Wesfarmers appears to offer strategic entry points:
Informations importantes
Short-Term: Although the RSI suggests a pause could materialise, the underlying momentum and strong support levels imply any pullback might be short-lived and could present an attractive tactical entry near the AUD 78.00–77.00 zone. Traders may find opportunities aligning positions ahead of upcoming earnings releases or major strategic announcements.
Medium-Term: Investors seeking exposure to structural themes—digital transformation, energy transition, health and wellness—can exploit the current uptrend to participate in Wesfarmers’ unfolding growth story. The consistent performance above all major moving averages offers additional conviction for layering into positions during any consolidations.
Long-Term: Wesfarmers’ diversified model, quality governance, and proactive sectoral expansion make it a compelling candidate for core portfolio allocation. Its alignment with demographic, technological, and regulatory megatrends supports ongoing capital appreciation, with the added benefit of steady dividend income enhanced by franking credits. For superannuation vehicles and long-horizon investors, the stock offers a blend of defensiveness and growth optionality.
In each timeframe, positioning ahead of catalysts (e.g., divisional results, lithium venture updates, further health sector moves) enhances return asymmetry, while strong technical support lessens downside risk.
Is it the Right Time to Buy Wesfarmers?
Synthesizing technical strength, accelerating earnings momentum, and a diversified catalyst pipeline, Wesfarmers presently stands out as one of the most compelling opportunities among Australian blue-chips. The company’s market leadership, earnings quality, and proactive transformation initiatives foster both resilience and growth—a rare combination amid shifting sector dynamics. While near-term technical indicators suggest intermittent consolidation is possible, the stock’s structural strengths and favorable sector positioning argue for sustained outperformance in 2025 and beyond.
With solid floors established by key technical supports, steadily rising volumes manifesting broad-based market confidence, and a valuation grounded in both defensive and expansionary logic, Wesfarmers seems to represent an excellent opportunity for investors seeking stability, growth, and access to Australia’s evolving economic engine. As the conglomerate harnesses the full potential of its digital, health, and energy ventures, the case for renewed consideration—and indeed, renewed interest—has seldom appeared stronger.
In a market defined by transition and innovation, Wesfarmers exemplifies the qualities investors seek for the next chapter of growth: financial solidity, visionary management, and a clear roadmap to value creation. The stock may well be entering a new bullish phase, and in this context, Wesfarmers deserves careful consideration as a strategic portfolio holding for 2025 and beyond.
How to buy Wesfarmers stock in Australia?
Buying Wesfarmers stock online is straightforward and secure when you use a regulated Australian broker. Whether you’re investing for the long term by buying shares directly or seeking to trade price movements through CFDs, both strategies can be accessed online in just a few clicks. Spot buying gives you actual ownership of Wesfarmers shares, while CFDs let you speculate on price changes with leverage, without owning the stock. Each method comes with its own features and costs, so it’s essential to understand the differences. For help choosing a broker, refer to our detailed comparison further down the page.
Cash buying
Buying Wesfarmers shares “for cash” means you purchase actual shares via your online broker and become a shareholder. This method entitles you to dividends (including franked dividends in Australia), allows you to vote in company meetings, and lets you benefit directly from price appreciation. Typical fees for online share trading in Australia are around a $5 fixed commission per buy order—some brokers may charge higher or lower, particularly for ASX-listed shares like Wesfarmers.
Informations importantes
For example: The current Wesfarmers share price is AUD $79.56. With a $1,000 investment, after a $5 brokerage fee, you can buy approximately 12 shares (exact figure: $1,000 - $5 = $995; $995 ÷ $79.56 ≈ 12.5 shares).
Gain scenario:
If the share price rises by 10%, your holdings would now be worth $1,100.
Result: That’s a $100 gross gain, or +10% on your initial investment.
Trading via CFD
CFD (Contract for Difference) trading allows you to speculate on Wesfarmers shares’ price movements without owning the stock. Instead of buying the actual shares, you enter into a contract with your broker to exchange the difference in price from opening to closing. CFDs enable the use of leverage (commonly up to 5x or more), so you can gain larger exposure with less capital. Fees typically include a spread (the difference between buy and sell price) and, if held overnight, daily financing charges.
Informations importantes
For example: With a $1,000 deposit and 5x leverage, you open a CFD position on Wesfarmers shares with $5,000 market exposure.
Gain scenario:
If Wesfarmers’ share price rises by 8%, your position gains 40% (8% × 5).
Result: That’s a $400 gain on your $1,000 position (excluding fees).
Final advice
Before you invest, it’s wise to compare brokers’ conditions, fees, and product offering. Look for competitive commissions, transparent fee structures, and features matched to your experience level and goals. Ultimately, the most appropriate approach—cash share buying versus CFD trading—depends on whether you want long-term investment and dividends, or shorter-term trading with leverage. You’ll find an updated broker comparator further down the page to help you find the best platform for your needs.
Is AvaTrade reliable?
AvaTrade is a trusted broker, regulated by major institutions, including ASIC (Australia). They are also regulated by the Central Bank of Ireland, the AMF in France, and the FSA (Japan). Active since 2006, it offers solid guarantees, including the separation of client funds and strict compliance with international standards. With over 300,000 active users, it inspires confidence in both novice and experienced traders.
Why choose AvaTrade?
AvaTrade combines simplicity and expertise. Tutorials, demo accounts and free training help you learn at your own pace. Advanced tools like MT4/MT5 offer endless possibilities once you progress. You don't need to be an expert: AvaTrade adapts to you.
What are the fees at AvaTrade?
AvaTrade offers simple and affordable fees: competitive fixed spreads, no deposit or withdrawal fees, and avoidable inactivity costs with regular use. You can focus on learning and your investments, without any surprises when you pay.
Who is AvaTrade for?
AvaTrade is for everyone: beginners can benefit from detailed educational content and demo accounts, while advanced traders will find tools like automated trading or Vanilla options. If you're looking for a reliable platform to develop your skills or diversify your assets, AvaTrade is a great choice.
Is AvaTrade reliable?
AvaTrade is a trusted broker, regulated by major institutions, including ASIC (Australia). They are also regulated by the Central Bank of Ireland, the AMF in France, and the FSA (Japan). Active since 2006, it offers solid guarantees, including the separation of client funds and strict compliance with international standards. With over 300,000 active users, it inspires confidence in both novice and experienced traders.
Why choose AvaTrade?
AvaTrade combines simplicity and expertise. Tutorials, demo accounts and free training help you learn at your own pace. Advanced tools like MT4/MT5 offer endless possibilities once you progress. You don't need to be an expert: AvaTrade adapts to you.
What are the fees at AvaTrade?
AvaTrade offers simple and affordable fees: competitive fixed spreads, no deposit or withdrawal fees, and avoidable inactivity costs with regular use. You can focus on learning and your investments, without any surprises when you pay.
Who is AvaTrade for?
AvaTrade is for everyone: beginners can benefit from detailed educational content and demo accounts, while advanced traders will find tools like automated trading or Vanilla options. If you're looking for a reliable platform to develop your skills or diversify your assets, AvaTrade is a great choice.
Is IG reliable?
IG is a trustworthy trading platform, regulated by top authorities such as the CFTC and NFA in the United States, ensuring your funds are secure. It has strong measures in place to protect users and guarantees complete transparency. Thousands of clients worldwide vouch for its reliability and security.
Why choose IG?
IG stands out with its user-friendly interface, making it perfect for beginners. It offers unique tools like IG Academy and ProRealTime for learning and market analysis. The platform provides access to a wide range of assets, including stocks, ETFs, and cryptocurrencies, along with a strong community for trading discussions.
What are the fees at IG?
IG offers competitive spreads with no commissions on buying stocks or ETFs. Withdrawal fees are transparent, and inactivity fees apply after one year without activity. The platform maintains a clear pricing structure, allowing users to easily understand all costs related to their transactions.
Who is IG for?
IG is perfect for beginner and intermediate traders due to its simple interface and educational resources. It also caters to experienced investors with advanced trading tools. Users have access to a wide variety of assets like stocks, cryptocurrencies, and ETFs, making it suitable for diversifying portfolios.
Is IG reliable?
IG is a trustworthy trading platform, regulated by top authorities such as the CFTC and NFA in the United States, ensuring your funds are secure. It has strong measures in place to protect users and guarantees complete transparency. Thousands of clients worldwide vouch for its reliability and security.
Why choose IG?
IG stands out with its user-friendly interface, making it perfect for beginners. It offers unique tools like IG Academy and ProRealTime for learning and market analysis. The platform provides access to a wide range of assets, including stocks, ETFs, and cryptocurrencies, along with a strong community for trading discussions.
What are the fees at IG?
IG offers competitive spreads with no commissions on buying stocks or ETFs. Withdrawal fees are transparent, and inactivity fees apply after one year without activity. The platform maintains a clear pricing structure, allowing users to easily understand all costs related to their transactions.
Who is IG for?
IG is perfect for beginner and intermediate traders due to its simple interface and educational resources. It also caters to experienced investors with advanced trading tools. Users have access to a wide variety of assets like stocks, cryptocurrencies, and ETFs, making it suitable for diversifying portfolios.
Is eToro reliable?
Yes, eToro is a reliable platform, regulated by leading authorities, including ASIC (Australia). It is also regulated by the FCA (UK) and CySEC (Europe). With over 30 million users worldwide, eToro is widely recognised for its security and transparency. Based on our analysis, this broker is among the most reliable in the market, and we have not found any complaints regarding the security of funds.
Why choose eToro?
With eToro, you don’t need to be an expert to get started. Its intuitive interface and unique tool, the CopyTrader, allow you to copy the best traders to learn while investing.
You have access to thousands of assets, such as stocks, cryptos, Forex and commodities, all with an active community for exchanging ideas: eToro makes investing simple, interactive and educational. It's a bit like the Spotify of investing.
What are the fees at eToro?
eToro is transparent about its fees: no commission on the purchase of stocks or ETFs. Spreads vary depending on the asset, but remain very affordable.
Deposits are free, and withdrawals are set at $5 USD. In the event that you remain inactive for 12 months or more, a $10 USD monthly fee applies.
Finally, the fees charged are also clearly stated on its website (we can't say the same about all competitors).
Who is eToro for?
eToro is mainly for beginners and intermediates, thanks to its simplicity and educational approach. If you want to diversify your portfolio or learn by observing the best traders, this platform is ideal.
Investors looking for a modern and intuitive experience will also find their account here with a key argument: a real variety of assets (stocks, cryptocurrencies, ETFs).
Is eToro reliable?
Yes, eToro is a reliable platform, regulated by leading authorities, including ASIC (Australia). It is also regulated by the FCA (UK) and CySEC (Europe). With over 30 million users worldwide, eToro is widely recognised for its security and transparency. Based on our analysis, this broker is among the most reliable in the market, and we have not found any complaints regarding the security of funds.
Why choose eToro?
With eToro, you don’t need to be an expert to get started. Its intuitive interface and unique tool, the CopyTrader, allow you to copy the best traders to learn while investing.
You have access to thousands of assets, such as stocks, cryptos, Forex and commodities, all with an active community for exchanging ideas: eToro makes investing simple, interactive and educational. It's a bit like the Spotify of investing.
What are the fees at eToro?
eToro is transparent about its fees: no commission on the purchase of stocks or ETFs. Spreads vary depending on the asset, but remain very affordable.
Deposits are free, and withdrawals are set at $5 USD. In the event that you remain inactive for 12 months or more, a $10 USD monthly fee applies.
Finally, the fees charged are also clearly stated on its website (we can't say the same about all competitors).
Who is eToro for?
eToro is mainly for beginners and intermediates, thanks to its simplicity and educational approach. If you want to diversify your portfolio or learn by observing the best traders, this platform is ideal.
Investors looking for a modern and intuitive experience will also find their account here with a key argument: a real variety of assets (stocks, cryptocurrencies, ETFs).
Our 7 tips for buying Wesfarmers stock
| Step | Specific tip for Wesfarmers |
|---|---|
| Analyse the market | Examine Wesfarmers’ diverse business model across retail, chemicals, and healthcare; consider Australia’s economic outlook and consumer trends impacting its divisions. |
| Choose the right trading platform | Select an ASX-accredited Australian broker that offers competitive fees, a user-friendly platform, and access to tax management for franked dividends. |
| Define your investment budget | Decide how much to invest based on your financial situation, keeping in mind Wesfarmers' size, relative stability, and the importance of diversification. |
| Choose a strategy (short or long term) | Consider a long-term approach to benefit from Wesfarmers’ ongoing digital investments and health sector growth, but stay alert to technical overbought signals in the short term. |
| Monitor news and financial results | Track Wesfarmers’ half-year and full-year earnings reports, major retail updates, and digital expansion news for timely insights into company momentum. |
| Use risk management tools | Utilise stop-loss orders and set profit targets to protect capital, especially if the stock experiences short-term corrections due to overbought conditions. |
| Sell at the right time | Review key resistance levels and analyst price targets; consider taking profits if the share price nears AUD 103 or if economic conditions start to weaken. |
The latest news about Wesfarmers
Wesfarmers shares have reached a new 52-week high, closing at AUD 79.56 on May 3, 2025, reflecting a weekly gain of 5.04%. This significant price momentum comes amid robust demand for blue-chip Australian companies, and Wesfarmers’ position as a retail and industrial leader has attracted both domestic and international institutional investment. The company's market capitalisation now stands at AUD 90.3 billion, reinforcing its status as one of the ASX’s largest and most stable conglomerates.
The latest half-year results showed continued strong performance, with revenue rising 3.6% year-on-year to AUD 23.49 billion and net profit after tax reaching AUD 1.467 billion. Wesfarmers’ diversified business model, with stable contributions from Bunnings, Kmart Group, Officeworks, and its expanding health and digital divisions, has underpinned this growth. Notably, earnings per share have increased, and the company continues to pay out a healthy, fully franked dividend, which remains attractive for Australian investors seeking both income and tax efficiency.
Technical indicators point to a strong uptrend for Wesfarmers shares, with the stock trading above all major moving averages and a MACD value of 1.63, though the current RSI of 74.06 highlights short-term overbought conditions. Market experts note that this momentum is built on sustained operational improvement and strong earnings visibility, though some analysts caution that a technical pullback could occur in the coming sessions. Still, the technical consensus remains overwhelmingly positive, and the analyst target price implies further upside potential from current levels.
Wesfarmers’ strategic expansion into digital and health sectors continues to generate optimism, especially as its OneDigital platform and health division drive future growth in Australia. Recent integration of Kmart and Target’s operations and systems is expected to deliver efficiencies and support further gains, while the company’s growing presence in healthcare through Priceline Pharmacy and associated businesses positions it favorably amid the sector’s strong local demand.
Participation in the lithium joint venture further diversifies Wesfarmers’ portfolio, positioning the group to benefit from the ongoing energy transition and resource sector tailwinds within Australia. This investment underlines Wesfarmers’ ability to capitalize on emerging opportunities in the local economy, ensuring relevance across multiple growth themes and buttressing long-term value creation for Australian shareholders.
FAQ
What is the latest dividend for Wesfarmers stock?
Wesfarmers currently pays a dividend, and its most recent dividend was AUD 0.88 per share, paid in March 2025. This continues its consistent track record of semi-annual dividend payments. The dividend yield is 2.54%, and dividends are typically fully franked, offering Australian investors tax advantages. Wesfarmers has a strong history of reliable distributions, reflecting its robust cash generation and stable financials.
What is the forecast for Wesfarmers stock in 2025, 2026, and 2027?
Based on recent prices, Wesfarmers is projected to reach approximately AUD 103.43 by the end of 2025, AUD 119.34 by the end of 2026, and AUD 159.12 by the end of 2027. These anticipated values reflect the company's positive sector momentum, ongoing expansion in digital and health divisions, and analyst confidence in its growth strategy.
Should I sell my Wesfarmers shares?
Holding onto Wesfarmers shares may be a sound strategy, considering its strong fundamentals and sector leadership. The company has demonstrated resilience through diverse business operations and steady financial performance over the years. With solid market positions and ongoing investments in digital and health sectors, Wesfarmers is well-placed for mid- to long-term growth. For investors, maintaining a position aligns with the company’s history of rewarding shareholders.
How are dividends from Wesfarmers taxed in Australia?
Dividends from Wesfarmers are generally fully franked, meaning they come with franking credits that offset Australian income tax for eligible investors. This reduces the effective tax paid on dividends, and any excess franking credits may be refundable or used to offset other tax liabilities. Australian residents benefit from this system, making Wesfarmers’ dividends particularly attractive from a tax perspective.
What is the latest dividend for Wesfarmers stock?
Wesfarmers currently pays a dividend, and its most recent dividend was AUD 0.88 per share, paid in March 2025. This continues its consistent track record of semi-annual dividend payments. The dividend yield is 2.54%, and dividends are typically fully franked, offering Australian investors tax advantages. Wesfarmers has a strong history of reliable distributions, reflecting its robust cash generation and stable financials.
What is the forecast for Wesfarmers stock in 2025, 2026, and 2027?
Based on recent prices, Wesfarmers is projected to reach approximately AUD 103.43 by the end of 2025, AUD 119.34 by the end of 2026, and AUD 159.12 by the end of 2027. These anticipated values reflect the company's positive sector momentum, ongoing expansion in digital and health divisions, and analyst confidence in its growth strategy.
Should I sell my Wesfarmers shares?
Holding onto Wesfarmers shares may be a sound strategy, considering its strong fundamentals and sector leadership. The company has demonstrated resilience through diverse business operations and steady financial performance over the years. With solid market positions and ongoing investments in digital and health sectors, Wesfarmers is well-placed for mid- to long-term growth. For investors, maintaining a position aligns with the company’s history of rewarding shareholders.
How are dividends from Wesfarmers taxed in Australia?
Dividends from Wesfarmers are generally fully franked, meaning they come with franking credits that offset Australian income tax for eligible investors. This reduces the effective tax paid on dividends, and any excess franking credits may be refundable or used to offset other tax liabilities. Australian residents benefit from this system, making Wesfarmers’ dividends particularly attractive from a tax perspective.
